Found: 18
Select item for more details and to access through your institution.
Blood unconjugated bilirubin and tacrolimus are negative predictors of specific cellular immunity in kidney transplant recipients after SAR-CoV-2 inactivated vaccination.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-29669-8
- By:
- Publication type:
- Article
Comparison of the Immunogenicity of HIV-1 CRF07_BC Gag Antigen With or Without a Seven Amino Acid Deletion in p6 Region.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.850719
- By:
- Publication type:
- Article
Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25312-0
- By:
- Publication type:
- Article
Vaccine with bacterium‐like particles displaying HIV‐1 gp120 trimer elicits specific mucosal responses and neutralizing antibodies in rhesus macaques.
- Published in:
- Microbial Biotechnology, 2022, v. 15, n. 7, p. 2022, doi. 10.1111/1751-7915.14022
- By:
- Publication type:
- Article
Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0072-6
- By:
- Publication type:
- Article
Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02415
- By:
- Publication type:
- Article
Regulation of SIV Antigen-Specific CD4+ T Cellular Immunity via Autophagosome-Mediated MHC II Molecule-Targeting Antigen Presentation in Mice.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0093143
- By:
- Publication type:
- Article
Phenotypic Characterization of Chinese Rhesus Macaque Plasmablasts for Cloning Antigen-Specific Monoclonal Antibodies.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02426
- By:
- Publication type:
- Article
Arsenic Trioxide Impacts Viral Latency and Delays Viral Rebound after Termination of ART in Chronically SIV‐Infected Macaques.
- Published in:
- Advanced Science, 2019, v. 6, n. 13, p. N.PAG, doi. 10.1002/advs.201900319
- By:
- Publication type:
- Article
PLA2G12A protects against diet‐induced obesity and insulin resistance by enhancing energy expenditure and clearance of circulating triglycerides.
- Published in:
- FASEB Journal, 2024, v. 38, n. 9, p. 1, doi. 10.1096/fj.202302075R
- By:
- Publication type:
- Article
Corrigendum: Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.582010
- By:
- Publication type:
- Article
Preexisting Virus-Specific T Lymphocytes-Mediated Enhancement of Adenovirus Infections to Human Blood CD14+ Cells.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 2, p. 154, doi. 10.3390/v11020154
- By:
- Publication type:
- Article
Vaccine Engineering with Dual-Functional Mineral Shell: A Promising Strategy to Overcome Preexisting Immunity.
- Published in:
- Advanced Materials, 2016, v. 28, n. 4, p. 694, doi. 10.1002/adma.201503740
- By:
- Publication type:
- Article
Immunization with an adenovirus-vectored TB vaccine containing Ag85A-Mtb32 effectively alleviates allergic asthma.
- Published in:
- Journal of Molecular Medicine, 2018, v. 96, n. 3/4, p. 249, doi. 10.1007/s00109-017-1614-5
- By:
- Publication type:
- Article
Correction To: Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01423-6
- By:
- Publication type:
- Article
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18077-5
- By:
- Publication type:
- Article